Neurofibromatosis type 1: Genetic and cellular mechanisms of peripheral nerve tumor formation

Neuroscientist

Volumn 3, Issue 6, 1997, Pages 712-720

  Rosenbaum, Thorsten ^a   Patrie, Kevin M ^b   Ratner, Nancy ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Neurofibroma; Neurofibromatosis; NF1; Ras; Schwann cell

Indexed keywords

EID: 3042916992     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (97)

1. Crowe FW, Schull WJ, Neel JV. A clinical, pathological, and genetic study of multiple neurofibromatosis. Springfield (IL): Charles C. Thomas; 1956.
2. Huson SM. Recent developments in the diagnosis and management of neurofibromatosis. Arch Dis Child 1989;64:745-749.
3. Viskochil D, White R, Cawthon R. The neurofibromatosis type 1 gene. Annu Rev Neurosci 1993;16:183-205.
4. Marchuk DA, Collins FS. Molecular genetics of neurofibromatosis 1. In: Huson SM, Hughes RAC, editors. The neurofibromatoses. A pathogenetic and clinical overview. London: Chapman and Hall; 1994. p. 23-49.
5. Easton DF, Ponder MA, Huson SM, Ponder BAJ. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): Evidence for modifying genes. Am J Hum Genet 1993;53:305-313.
6. Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 1996;33:2-17.
7. Mulvihill JJ, Parry DM, Sherman JL, Pikus A, Kaiser-Kupfer MI, Eldridge R. NIH conference: neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med 1990;113:39-52.
8. North K, et al. Cognitive function and academic performance in neurofibromatosis 1. Neurology. In press 1997.
9. von Recklinghausen FD. Ueber die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen. Berlin: Hirschwald; 1882.
10. Riccardi VM. Neurofibromatosis: phenotype, natural history, and pathogenesis. 2nd ed. Baltimore (MD): Johns Hopkins University Press; 1992.
11. Bolande RP. Neurofibromatosis - the quintessential neurocristopathy: pathogenetic concepts and relationships. Adv Neurol 1981; 29:67-75.
12. Mulvihill JJ. Malignancy: epidemiologically associated cancers. In: Huson SM, Hughes RAC, editors. The neurofibromatoses. A pathogenetic and clinical overview. London: Chapman and Hall; 1994. p. 305-315.
13. Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. N Engl J Med 1986;314: 1010-1014.
14. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986;57:2006-2021.
15. Ryan JJ, Klein KA, Neuberger TJ, et al. Role for the stem cell factor/KIT complex in Schwann cell neoplasia and mast cell proliferation associated with neurofibromatosis. J Neurosci Res 1994; 37:415-432.
16. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971;68:820-823.
17. Levine AJ. Tumor suppressor genes. In: Mendelsohn J, Howley PM, Israel MA, Liotta LA, editors. The molecular basis of cancer. Philadelphia: Saunders; 1995. p. 86-104.
18. Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 1994;330:597-601.
19. Gutmann DH, Cole JL, Stone WJ, Ponder BA, Collins FS. Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I. Genes Chromosom Cancer 1994;10:55-58.
20. Legius E, Marchuk DA, Collins FS, Glover TW. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 1993;3: 122-126.
21. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87:159-170.
22. Menon AG, Anderson KM, Riccardi VM, et al. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A 1990;87:5435-5439.
23. Legius E, Dierick H, Wu R, et al. TP53 mutations are frequent in malignant NF1 tumors. Genes Chromosom Cancer 1994;10:250-255.
24. Lothe RA, Sletta A, Sæter G, Brøgger A, Børresen AL, Nesland JM. Alterations at chromosome 17 loci in peripheral nerve sheath tumors. J Neuropathol Exp Neural 1995;54:65-73.
25. Halling KC, Scheithauer BW, Halling AC, et al. p53 expression in neurofibroma and malignant peripheral nerve sheath tumor. An immunohistochemical study of sporadic and NF1-associated tumors. Am J Clin Pathol 1996;106:282-288.
26. Lothe RA, Karhu R, Mandahl N, et al. Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis. Cancer Res 1996;56:4778-4781.
27. Li Y, O'Connell P, Breidenbach HH, et al. Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics 1995;25:9-18.
28. Cummings LM, Trent JM, Marchuk DA. Identification and mapping of type 1 neurofibromatosis (NF1) homologous loci. Cytogenet Cell Genet 1996;73:334-340.
29. Hulsebos TJ, Bijleveld EH, Riegman PH, Smink LJ, Dunham I. Identification and characterization of NF1-related loci on human chromosomes 22, 14 and 2. Hum Genet 1996;98:7-11.
30. McCormick F. Ras signaling and NF1. Curr Opin Genet Dev 1995;5:51-55.
31. Guha A, Lau N, Huvar I, et al. Ras-GTP levels are elevated in human NF1 peripheral nerve rumors. Oncogene 1996;12:507-513.
32. Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J. Aberrant regulation of ras proteins in malignant tumor cells from type 1 neurofibromatosis patients. Nature 1992; 356:713-715.
33. ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 1992;69: 265-273.
34. Bollag G, Clapp DW, Shih S, et al. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 1996;12:144-148.
35. Yan N, Ricca C, Fletcher J, Glover T, Seizinger BR, Manne V. Farnesyltransferase inhibitors block the neurofibromatosis type 1 (NF1) malignant phenotype. Cancer Res 1995;55:3569-3575.
36. Johnson MR, DeClue JE, Felzmann S, et al. Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol Cell Biol 1994;14:641-645.
37. Johnson MR, Look AT, DeClue JE, Valentine MB, Lowy DR. Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTPáRas. Proc Natl Acad Sci U S A 1993;90:5539-5543.
38. Graham SM, Vojtek AB, Huff SY, et al. TC21 causes transformation by Raf-independent signaling pathways. Mol Cell Biol 1996;16:6132-6140.
39. Wiestler OD, Radner H. Pathology of neurofibromatosis 1 and 2. In: Huson SM, Hughes RAC, editors. The neurofibromatoses. A pathogenetic and clinical overview. London: Chapman and Hall; 1994. p. 135-159.
40. Uitto J, Matsuoka LY, Chu M-L, Pihlajaniemi T, Prockop DJ. Connective tissue biochemistry of neurofibromas. Ann N Y Acad Sci 1986;486:271-286.
41. Konomi H, Arima M, Tanaka H, Hayashi T, Ikeda S. Increased deposition of types III and V collagen in neurofibroma tissue from patients with von Recklinghausen disease. Brain Dev 1989;11: 378-383.
42. Peltonen J, Jaakkola S, Lebwohl M, et al. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 1988;59:760-771.
43. Sheela S, Riccardi VM, Ratner N. Angiogenic and invasive properties of neurofibroma Schwann cells. J Cell Biol 1990;111:645-653.
44. Lee JK, Sobel RA, Ciocca EA, Kim TS, Martuza RL. Growth of human acoustic neuromas, neurofibromas and schwannomas in the subrenal capsule and sciatic nerve of the nude mouse. J Neurooncol 1992;14:101-112.
45. Krasnoselsky A, Massay MJ, DeFrances MC, Michalopoulos G, Zarnegar R, Ratner N. Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas. J Neurosci 1994; 14:7284-7290.
46. Ratner N, Lieberman MA, Riccardi VM, Hong D. Mitogen accumulation in von Recklinghausen neurofibromatosis. Ann Neurol 1990;27:298-303.
47. Hansson HA, Lauritzen C, Lossing C, Petruson K. Somatomedin C as a tentative pathogenic factor in neurofibromatosis. Scand J Plast Reconstr Surg Hand Surg 1988;22:7-13.
48. Riccardi VM. The potential role of trauma and mast cells in the pathogenesis of neurofibromas. In: Ishibashi Y, Hori Y, editors. Tuberosis sclerosis and neurofibromatosis: epidemiology, pathophysiology, biology and management. Amsterdam: Elsevier; 1990. p. 167-190.
49. Nurnberger M, Moll I. Semiquantitative aspects of mast cells in normal skin and in neurofibromas of neurofibromatosis types 1 and 2. Dermatology 1994;188:296-299.
50. Carr NJ, Warren AY. Mast cell numbers in melanocytic nevi and cutaneous neurofibromas. J Clin Pathol 1993;46:86-87.
51. Muir D. Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression. Clin Exp Metastasis 1995;13: 303-314.
52. Colman SD, Williams CA, Wallace MR. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 1995;11:90-92.
53. Sawada S, Florell S, Purandare SM, Ota M, Stephens K, Viskochil D. Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat Genet 1996;14:110-112.
54. Stark M, Assum G, Krone W. Single-cell PCR performed with neurofibroma Schwann cells reveals the presence of both alleles of the neurofibromatosis type 1 (NF1) gene. Hum Genet 1995;96: 619-623.
55. Ottini L, Esposito DL, Richetta A, et al. Alterations of microsatellites in neurofibromas of von Recklinghausen's disease. Cancer Res 1995;55:5677-5680.
56. Huynh DP, Nechiporuk T, Pulst SM. Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development. Dev Biol 1994;161:538-551.
57. Daston M, Ratner N. Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development. Dev Dyn 1992;195:216-226.
58. Gutmann DH, Cole JL, Collins FS. Expression of the neurofibromatosis type 1 (NF1) gene during mouse embryonic development. Prog Brain Res 1995;105:327-335.
59. Stocker KM, Baizer L, Coston T, Sherman L, Ciment G. Regulated expression of neurofibromin in migrating neural crest cells of avian embryos. J Neurobiol 1995;27:535-552.
60. Daston MM, Scrable H, Nordlund M, Sturbaum AK, Nissen LM, Ratner N. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes. Neuron 1992;8:415-428.
61. Gutmann DH, Geist RT, Wright DE, Snider WD. Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues. Cell Growth Differ 1995;6:315-323.
62. Wrabetz L, Feltri ML, Kim H, et al. Regulation of neurofibromin expression in rat sciatic nerve and cultured Schwann cells. Glia 1995;15:22-32.
63. Gutmann DH, Tennekoon GI, Cole JL, Collins FS, Rutkowski JL. Modulation of the neurofibromatosis type 1 product, neurofibromin, during Schwann cell differentiation. J Neurosci Res 1993; 36:216-223.
64. Malhotra R, Ratner N. Location of neurofibromin to keratinocytes and melanocytes in developing rat and human skin. J Invest Dermatol 1994;102:812-818.
65. Hermonen J, Hirvonen O, Yla-Outinen H, et al. Neurofibromin: expression by normal human keratinocytes in vivo and in vitro and in epidermal malignancies. Lab Invest 1995;73:221-228.
66. Nordlund ML, Rizvi TA, Brannan CI, Ratner N. Neurofibromin expression and astrogliosis in neurofibromatosis (type 1) brains. J Neuropathol Exp Neurol 1995;54:588-600.
67. Davis FA. Primary tumors of the optic nerve (a phenomenon of Recklinghausen's disease). Arch Ophthalmol 1940;23:735-821, 957-1022.
68. Vaalasti A, Suomalainen H, Kuokkanen K, Rechardt L. Neuropeptides in cutaneous neurofibromas of von Recklinghausen's disease. J Cutan Pathol 1990;17:371-373.
69. Stefansson K, Wollmann R, Jerkovic M. S-100 protein in soft tissue tumours derived from Schwann cells and melanocytes. Am J Pathol 1982;106:261-268.
70. Wagenner JD. Ultrastructure of benign peripheral nerve sheath tumors. Cancer 1966;19:699-709.
71. Baron P, Kreider B. Axons induce differentiation of neurofibroma Schwann-like cells. Acta Neuropathol (Berl) 1991;81:491-495.
72. Penfield W. Tumors of the sheaths of the nervous system. Arch Neurol Psychiat 1932;27:1298-1309.
73. Murray MR, Stout AP, Bradley CF. Schwann cell versus fibroblasts as origin of specific nerve sheath rumor; observations upon normal nerve sheaths and neurilemomas in vitro. Am J Pathol 1940;16:41-60.
74. Mühleck O, Krone W, Mao R, Weber L. Cell culture studies on neurofibromatosis (von Recklinghausen's disease): IV. Collagen synthesis. Arch Dermatol Res 1986;278:232-237.
75. Peltonen J, Marttala T, Vihersaari T, Renvall S, Penttinen R. Collagen synthesis in cells cultured from v. Recklinghausen's neurofibromatosis. Acta Neuropathol (Berl) 1981;55:183-187.
76. Sasaki T, Agai K, Nagai Y. Growth and collagen synthesis of cultured neurofibroma fibroblasts. J Dermatol 1992;19:598-601.
77. Rosenbaum T, Boissy YL, Kombrinck K, et al. Neurofibromin-deficient fibroblasts fail to form perineurium in vitro. Development 1995;121:3583-3592.
78. Schober R, Vogeley KT, Urich H, Hölzle E, Wechsler W. Vascular permeability changes in tumors of the peripheral nervous system. Virchows Archiv A Pathol Anat Histopathol 1992;420:59-64.
79. Silva AJ, Frankland PW, Marowitz Z, et al. A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet 1997;15:281-284.
80. DiPaolo DP, Zimmerman RA, Rorke LB, Zackai EH, Bilaniuk LT, Yachnis AT. Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology 1995;195:721-724.
81. Nordlund M, Gu X, Shipley MT, Ratner N. Neurofibromin is enriched in the endoplasmic reticulum of CNS neurons. J Neurosci 1993;13:1588-1600.
82. Giordano MJ, Mahadeo DK, He YY, Geist RT, Hsu C, Gutmann DH. Increased expression of the neurofibromatosis 1 (NF1) gene product, neurofibromin, in astrocytes in response to cerebral ischemia. J Neurosci Res 1996;43:246-253.
83. Fawcett JW, Keynes RJ. Peripheral nerve regeneration. Annu Rev Neurosci 1990;13:43-60.
84. Dugoff L, Sujansky E. Neurofibromatosis type 1 and pregnancy. Am J Med Genet 1996;66:7-10.
85. Cohen JS, Nies B, Tifft CJ. Neurofibromatosis type 1 and pregnancy. Am J Hum Genet 1994;55:A9.
86. Riccardi VM, Womack JE, Jacks T. Neurofibromatosis and related tumors. Natural occurrence and animal models. Am J Pathol 1994; 145:994-1000.
87. Feigenbaum L, Kazuyuki F, Collins FS, Jay G. Repression of the NF1 gene by Tax may explain the development of neurofibromas in human T-lymphotropic virus type 1 transgenic mice. J Virology 1996;70:3280-3285.
88. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA. Tumour predisposition in mice heterozygous for a targeted mutation in NF1. Nat Genet 1994;7:353-361.
89. Brannan CI, Perkins AS, Vogel KS, et al. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 1994;8:1019-1029.
90. Rizvi T, Ratner N. Hyperpigmentation and tumor formation following nerve wounding in NF1/nf1 mice. J Neurosci 1996;22: 317a.
91. Largaespada DA, Brannan CI, Jenkins NA, Copeland NG. Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia. Nat Genet 1996;12:137-143.
92. Guo H-F, The I, Hannan F, Bernards A, Zhong Y. Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science 1997;276:795-798.
93. Vogel KS, Brannan CI, Jenkins NA, Copeland NG, Parada LF. Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell 1995; 82:733-742.
94. Kim H, Ling B, Ratner N. NF1-deficient mouse Schwann cells are angiogenic, invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase. Mol Cell Biol 1997;17:862-872.
95. ras, inhibition of cell proliferation and morphological changes. Oncogene 1995;11:325-335.
96. Vogel KS, El-Afandi M, Klesse L, Parada LF. Neurofibromin negatively regulates neurotrophin signalling in embryonic sensory neurons. Soc Neurosci 1996;22:1476a.
97. Ridley AJ, Paterson HF, Noble M, Land H. ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J 1988;7:1635-1645.